EVIDENCE & NEW CHALLENGES IN RECTAL CANCER
Madrid • Spain
7-10 October 2012
Early rate deadline: 9 July 2012
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
Course Director
Vincenzo Valentini, Radiation Oncologist, Università Cattolica S. Cuore, Rome (IT)
Teachers
Regina Beets-Tan, Radiologist, University Hospital Maastricht, Maastricht (NL)
Josep M Borras, Epidemiologist, Cancer Plan, Dept. of Health. L'Hospitalet de Llobregat. Barcelona (ES)
Claudio Coco, Surgeon, Università Cattolica S.Cuore, Rome (IT)
Karin Haustermans, Radiation Oncologist, University Hospital Gasthuisberg, KU-Leuven (BE)
Corrie Marijnen, Radiation Oncologist, Leids Universitair Medisch Centrum, Leiden (NL)
Lars Påhlman, Surgeon, Uppsala University Hospital, Uppsala (SE)
Claus Rödel, Radiation Oncologist, University Hospital Erlangen, Erlangen (DE)
Hans Joachim Schmoll, Medical Oncologist, Martin Luther University Halle-Wittenberg, Halle (DE)
Nigel Scott, Pathologist, St James¹s University Hospital, Leeds (UK)
Cornelius Van de Velde, Surgeon, Leiden University Medical Center, Leiden (NL)
Delineation Administrator
Maria Antonietta Gambacorta, Radiation Oncologist, Università Cattolica S. Cuore, Rome (IT)
Local teachers
A. Cervantes, Medical Oncologist, University Hospital of Valencia (ES)
Felipe Calvo, Radiation Oncologist, Hospital Gregorio Marañón, Madrid (ES)
Héctor Ortiz, Surgeon, Hospital Virgen del Camino, Pamplona (ES)
Local organiser
Felipe Calvo, Radiation Oncologist, Hospital Gregorio Marañón, Madrid (ES)
Course aim
This course, jointly organized by ESTRO, ESSO and ESMO, seeks to promote an integrated approach, between all specialists involved in rectal cancer, to tailor the best treatment for each individual patient. The most relevant ongoing questions in multidisciplinary management of rectal cancer patients will be addressed in open debates and interaction with experts. In a truly multidisciplinary atmosphere, you will be able to identify the major uncertainties of the daily practice and learn how to handle them. You will have the opportunity to design a new research, starting from available state of the art evidences. The presence of colleagues with different specialties, from all over the world, will enrich your perspective and your daily practice. Don’t miss this chance to encounter the best science in rectal cancer patients’ management.
Target Group
The target group consists of surgeons, radiotherapists and medical oncologists involved in the multidisciplinary treatment of rectal cancer.
Educational programme
see details here >>>